Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (1373)

« Back to Publications

CONSORT 2025 statement: updated guideline for reporting randomised trials.

Hopewell S. et al, (2025), Lancet

Patient and public involvement in research reporting.

Staniszewska S. et al, (2025), Bmj, 389

The impact of complications on quality of life and mortality after hip fracture

Goh EL. et al, (2025), Bone and joint journal

The World Hip Trauma Evaluation (WHiTE) platform trial: a framework for randomized comparisons of interventions for fragility hip fracture.

Costa ML. et al, (2025), Bone jt open, 6, 383 - 390

A 3-week pause versus continued Bruton tyrosine kinase inhibitor use during COVID-19 vaccination in individuals with chronic lymphocytic leukaemia (IMPROVE trial): a randomised, open-label, superiority trial.

Cook JA. et al, (2025), Lancet haematol, 12, e294 - e303

Describing the landscape of nutrition- and diet-related randomized controlled trials: metaresearch study of protocols published between 2012 and 2022.

Silva FM. et al, (2025), Am j clin nutr, 121, 882 - 891

Development of the the rehabilitation interventions for people with an acute patellar dislocation in the PRePPeD (Physiotherapy Rehabilitation Post Patellar Dislocation (PRePPeD) pilot randomized controlled trial

Forde C. et al, (2025), Bone and joint open

Local anaesthetic transperineal biopsy versus transrectal prostate biopsy in prostate cancer detection (TRANSLATE): a multicentre, randomised, controlled trial.

Bryant RJ. et al, (2025), Lancet oncol

Effect of a 2-week interruption in methotrexate treatment versus continued treatment on COVID-19 booster vaccine immunity in adults with inflammatory conditions (VROOM study): a randomised, open label, superiority trial

(2025), Efficacy and mechanism evaluation, 1 - 2

The risk of complications after hip fracture.

Goh EL. et al, (2025), Bone joint j, 107-B, 362 - 367

Guidance for protocol content and reporting of factorial randomised trials: explanation and elaboration of the CONSORT 2010 and SPIRIT 2013 extensions.

Kahan BC. et al, (2025), Bmj, 388

Prevalence of complications in older adults after hip fracture surgery: a systematic review and meta-analysis

Goh E. et al, (2025), Bone and joint journal, 107-B, 139 - 148

Developing generic clinical trial animated explainer videos in the UK: results of a survey and case study.

Calvert C. et al, (2025), Trials, 26

A simulation study showed that linear regression and Mann-Whitney test can be used to analyse the Days Alive and at Home by day 30 (DAH30) outcome in a randomized controlled trial.

Cook JA., (2025), J clin epidemiol

CONSORT-DEFINE explanation and elaboration: recommendations for enhancing reporting quality and impact of early phase dose-finding clinical trials.

Rekowski J. et al, (2025), Eclinicalmedicine, 79

SPIRIT-DEFINE explanation and elaboration: recommendations for enhancing quality and impact of early phase dose-finding clinical trials protocols.

Ursino M. et al, (2025), Eclinicalmedicine, 79

Integrating environmental outcomes in randomised clinical trials: a call to action.

Petersen JJ. et al, (2024), Lancet

Evidence for local anaesthetic transperineal biopsy versus transrectal prostate biopsy.

Lamb AD. et al, (2024), Bmj, 387

Facilitating the transition from hospital to home after hip fracture surgery: a qualitative study from the HIP HELPER trial.

Welsh A. et al, (2024), Bmc geriatr, 24

Immune microenvironment modulation following neoadjuvant therapy for oesophageal adenocarcinoma: a translational analysis of the DEBIOC clinical trial.

Scanlon E. et al, (2024), Esmo open, 9

Load More

1
2
3
4
5
6
7
...
»

Include forthcoming?